Production of human tissue-type plasminogen activator (htPA) using in vitro cultured transgenic pig mammary gland cells

Anim Biotechnol. 2019 Oct;30(4):317-322. doi: 10.1080/10495398.2018.1521824. Epub 2018 Dec 6.

Abstract

Tissue plasminogen activator (tPA) is a protein involved in the breakdown of blood clots. We have previously produced a human tPA (htPA)-overexpressing transgenic pig using a mammary gland-specific promoter. In this study, we have established a transgenic pig mammary gland cell line that produces recombinant htPA. The mammary gland cells grew well and retained their character over long periods of culture. There was no difference in the extent of apoptosis in transgenic cells compared to wild-type mammary gland cells. In addition, the transgenic mammary gland cells expressed and secreted htPA into the conditioned media at a concentration similar to that in milk. This transgenic cell line represents a simple and ethical method for recombinant htPA production.

Keywords: culture; mammary gland cell; protein expression; tissue-type plasminogen activator (tPA); transgenic pig.

MeSH terms

  • Animals
  • Animals, Genetically Modified
  • Cell Line
  • Cells, Cultured
  • Female
  • Humans
  • Mammary Glands, Animal / metabolism*
  • Milk / metabolism
  • Promoter Regions, Genetic
  • Recombinant Proteins / biosynthesis
  • Swine / genetics
  • Tissue Plasminogen Activator / biosynthesis*
  • Tissue Plasminogen Activator / genetics

Substances

  • Recombinant Proteins
  • PLAT protein, human
  • Tissue Plasminogen Activator